Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.9 USD 0.85% Market Closed
Market Cap: 339.2m USD
Have any thoughts about
Kamada Ltd?
Write Note
KMDA
/
Income Statement
/
Cost of Revenue

Kamada Ltd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kamada Ltd
Cost of Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Cost of Revenue
-$91m
CAGR 3-Years
-19%
CAGR 5-Years
-2%
CAGR 10-Years
-5%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Cost of Revenue
-$1.1m
CAGR 3-Years
28%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Cost of Revenue
-$8.7m
CAGR 3-Years
-27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Cost of Revenue
-$90k
CAGR 3-Years
33%
CAGR 5-Years
2%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Cost of Revenue
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Pluri Inc
NASDAQ:PLUR
Cost of Revenue
-$130k
CAGR 3-Years
N/A
CAGR 5-Years
-130%
CAGR 10-Years
-28%
No Stocks Found

Kamada Ltd
Glance View

Market Cap
339.1m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
5.83 USD
Overvaluation 1%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Kamada Ltd's Cost of Revenue?
Cost of Revenue
-91m USD

Based on the financial report for Sep 30, 2024, Kamada Ltd's Cost of Revenue amounts to -91m USD.

What is Kamada Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-5%

Over the last year, the Cost of Revenue growth was 4%. The average annual Cost of Revenue growth rates for Kamada Ltd have been -19% over the past three years , -2% over the past five years , and -5% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.